Latest News
LENZ Therapeutics, Inc.
- LENZ Therapeutics to Report Third Quarter 2026 Financial Results on October 29, 2026
- Millennium Management Reveals 3.7% Stake in LENZ Therapeutics via Schedule 13G Amendment
- Why Did LENZ Therapeutics (NASDAQ:LENZ) Rise 5.59% to USD 3.59?
- Insiders Re-Evaluate Their US$654.9k Stock Purchase As LENZ Therapeutics Falls To US$113m
- LENZ Q2 2026 Earnings: Narrower-Than-Expected Loss Per Share, but Shares Slip - Management Tone Analysis
- LENZ Therapeutics (LENZ): VIZZ Launch Turns Earnings Into a Cash-Runway Test
- LENZ Therapeutics: Below Cash For A Reason (NASDAQ:LENZ)
- Investigation launched into LENZ Therapeutics o...
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LENZ Therapeutics, Inc. - LENZ
Headlines from the last 30 days, linking to the original publishers. See all market news →